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Abstract  
It is unknown whether associations between blood pressure and stroke vary between 
Europeans and South Asians, despite higher stroke rates in the latter. We report findings from 
a UK cohort study of 1375 European and 1074 South Asian men, not receiving anti-
hypertensive medication, aged 40-69 years at baseline (1988-91). Assessment included blood 
pressure, blood tests, anthropometry, and questionnaires. Incident stroke was established at 
20 years from death certification, hospital and primary care records, and participant report. 
South Asians had higher systolic (SBP), diastolic (DBP) and mean arterial (MAP) blood 
pressure than Europeans, and similar pulse pressure (PP). Associations between SBP or DBP 
and stroke were stronger in South Asians than Europeans, after adjustment  for age, smoking 
status, waist/hip ratio, total/HDL-cholesterol ratio, diabetes, fasting glucose, physical activity, 
and heart rate (SBP: Europeans;(OR(95% CI) 1.22(0.98,1.51), South Asians;1.56(1.24,1.95), 
ethnic difference p=0.04, DBP: Europeans;0.90(0.71,1.13), South Asians;1.68(1.32,2.15), 
p<0.001). Haemodynamic correlates of stroke risk differed by ethnicity: in combined models, 
MAP but not PP was detrimentally associated with stroke in South Asians, whilst the 
converse was true for Europeans. The combination of hyperglycaemia and hypertension 
appeared particularly detrimental for South Asians. There are marked ethnic differences in 
associations between BP parameters and stroke. Undue focus on SBP for risk prediction, and 
current age and treatment thresholds may be inappropriate for individuals of South Asian 
ancestry. 
Keywords: blood pressure, stroke, ethnic differences, South Asians 
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Introduction  
Stroke is the second leading cause of death globally, with high blood pressure (BP) the 
strongest risk factor.1-3 South Asians  experience a 1·5-2 fold higher stroke risk than 
Europeans.4 Differences in hypertension prevalence between South Asians and Europeans do 
not explain the greater stroke risk in South Asian groups,5, 6 however associations between 
BP and its constituents (i.e. systolic BP (SBP), diastolic BP (DBP), or, from a haemodynamic 
perspective, mean arterial pressure (MAP) and pulse pressure (PP)) and stroke risk have not 
been compared directly in South Asians and Europeans. This is important as studies in 
European-origin populations indicate that SBP or PP are the major drivers of risk;7 
consequently it has been proposed that SBP should be the sole target for intervention,8 and 
many risk estimators only include SBP in their calculations.9, 10 Such assumptions need to be 
tested in non-European populations.  Furthermore, diabetes is much more prevalent in South 
Asian than European populations,5 and increases stroke risk independent of other 
cardiovascular risk factors,11 but the influence of hyperglycaemia on associations between BP 
and stroke risk in the former group is unexplored. 
Using data from a community-based follow-up study, we compared associations between BP 
constituents and stroke in South Asian and European men, and secondly explored reasons for 
differences, e.g. inter-ethnic variation in glycaemia. 
Methods  
Study participants and design 
The SABRE study is a multi-ethnic cohort study; details are published elsewhere.12 
Participants aged 40-69 years at baseline (1988-1991, n=4857) were randomly selected from 
primary care physician lists and workplaces in north-west London. South Asian participants 
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were first-generation migrants originating from the Indian subcontinent. All participants were 
followed for death, hospitalisation, and primary care consultations from baseline to 2011 
(outcome data were available for 4196). We report findings from a subset of 1375 European 
and 1074 South Asian men without stroke at baseline, who were not in receipt of baseline 
anti-hypertensive medication (figure 1).  
All participants gave written informed consent. Approval for the baseline study was obtained 
from Ealing, Hounslow and Spelthorne, Parkside and University College London research 
ethics committees, and at follow-up from St. Mary’s Hospital Local Research Ethics 
Committee (reference: 07/HO712/109).  
Baseline and follow-up measurements 
Participants underwent anthropometric measurement, and completed a health, lifestyle and 
occupation questionnaire. Physical activity comprised the total weekly energy expended (MJ) 
on sports, walking, cycling and daily activities. Circulating lipids, fasting and post-load 
glucose, and insulin and HbA1c were measured, as described.
12 Physician diagnosis or World 
Health Organization 1999 criteria for fasting and oral glucose tolerance test blood glucose 
measurements13 defined diabetes. HOMA2-IR was used to quantify insulin resistance.14 
Renal function was quantified by estimated glomerular filtration rate (eGFR), using the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) validated equations.15 
Between 2008 and 2011, survivors were invited for examination at St. Mary’s hospital, 
London. New cases of diabetes since baseline were identified from record review, 
questionnaire, clinic blood results, or death certificate data (ICD-9: 2500-2509, ICD-10: 
E100-E149).  Atrial fibrillation or flutter (AF) at follow-up was established from record 
review, questionnaire, and hospital episode statistics (HES) (ICD-9: 4273, ICD-10: I48). 
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Incident stroke was defined as the first post-baseline event from the following sources: death 
certification data (ICD-9: 430-439, ICD-10: I600-I698), HES (ICD codes as above), primary 
care record review adjudicated by two clinicians, as per Anglo-Scandinavian Cardiac 
Outcomes Trial criteria16 and participant report of physician-diagnosed stroke with duration 
of symptoms≥ 24 h.  
Seated resting brachial blood pressure and heart rate were measured at baseline after a 15 
minute rest using a random zero sphygmomanometer (Hawksley, London, United Kingdom) 
and at follow-up using an Omron 705IT; the mean of two measurements from each time point 
was used in analyses. A correction was applied to follow-up BP measurements (SBP: 
minus1·35mmHg, DBP: minus1·97mmHg) to ensure comparability with those at baseline, 
since the Hawksley random zero sphygmomanometer may under-estimate BP when 
compared with a standard mercury sphygmomanometer17. Concordance correlation 
coefficients18 for 30 inter-observer repeated measurements of follow-up SBP and DBP were 
0.78 and 0.89 respectively. Mean arterial pressure (MAP) was calculated as DBP + ((1/3) x 
(SBP – DBP)). 
Statistical analysis 
Baseline characteristics were compared by follow-up status, incident stroke and ethnicity. 
Logistic and linear regression methods determined age-adjusted differences.  
Associations between a 1 standard deviation (SD) increase in SBP, DBP, MAP, and PP and 
incident stroke were studied using age-adjusted logistic regression models. We then 
additionally adjusted these models for potential confounders (smoking, waist/hip ratio 
(WHR), total/ HDL-cholesterol (TC/HDL) ratio, diabetes, fasting glucose, physical activity, 
and heart rate). Smoking status and TC/HDL ratio were deemed potential confounders a 
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priori,19 whilst the remainder were selected on the basis of associations (p<0·10) with stroke 
in either ethnic group (table 1). Interactions between BP measures and ethnicity were sought 
in all models. Additionally, we inspected models with BP measures in combination (SBP + 
DBP, or MAP + PP) by ethnicity. We elected to use logistic regression as the proportional 
hazards assumption was violated for several models when using Cox regression techniques. 
We further explored ethnic differences in associations between BP and stroke by inspecting 
interaction terms between BP measures and baseline diabetes, fasting glucose, HbA1c, or 
HOMA2-IR in models of stroke for each ethnic group. This analysis was extended by 
graphically displaying stroke incidence by dichotomised SBP or DBP plotted against 
dichotomised HbA1c or fasting glucose for each ethnic group. Next, we compared 
associations between age and SBP or DBP in each ethnic group, to establish whether age-
related trends in BP differed by ethnicity. Subsequently, for participants with BP data at 
follow-up, we subtracted follow-up BP (with correction applied, see earlier) from baseline BP 
to elucidate ethnic differences in BP change over time, whether associations between BP 
change and stroke risk varied by ethnicity, and if this effect was modified by diabetes. 
Following this, for individuals in receipt of anti-hypertensive medication, we examined 
ethnic differences in SBP, DBP and BP control (defined as BP≤140/90 mmHg) by diabetes 
status at follow-up. Finally, we contrasted rates of anti-hypertensive use by ethnicity for 
people with BP>140/90 mmHg at baseline and follow-up, to establish ethnic differences in 
hypertension management. 
Sensitivity analyses were conducted by: a) including individuals in receipt of baseline anti-
hypertensive medication, adding 10/5 mmHg to BPs of those receiving treatment,20 b) 
excluding people with baseline diabetes, c) adjusting for diabetes as a time-varying covariate, 
d) adjusting for HbA1c or HOMA2-IR instead of fasting glucose, e) using the alternative 
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formula for MAP (MAP=DBP + 0·4 x PP) proposed by Bos,21 f) adjusting for follow-up use 
of anti-thrombotic medication (anti-platelets or anti-coagulant agents), g) adjusting for 
presence of atrial fibrillation/ flutter at follow-up (the latter two variables were not available 
at baseline),  h) adjusting for body mass index instead of waist/ hip ratio and i) additionally 
adjusting for eGFR in CVD risk factor-adjusted models (as a sensitivity analysis due to lower 
data availability). We repeated analyses by age sub-group (<55 years and ≥55 years). 
Results  
A total of 1375 (87%) European and 1074 (88%) South Asian men had complete data for 
baseline BP measures and stroke follow-up (figure 1). There were no consistent differences in 
baseline characteristics by follow-up status. Over a median of 20 years follow-up, incident 
stroke was higher in South Asians (n=102, 10%, p=0·02) than Europeans (n=104, 8%). South 
Asian men were more centrally obese, with more adverse lipid and glycaemic profiles and 
blood pressure measures than European men (table 1). The exception to this was PP, which 
was similar by ethnicity.  
All measures of BP (SBP, DBP, MAP and PP) were strongly positively associated with 
incident stroke in South Asians, even on multivariable adjustment (table 2).  In contrast, with 
the exception of PP, associations were either weaker (SBP) or absent for Europeans.  These 
ethnic differences in associations between BP and stroke risk were significant as interactions. 
When both SBP and DBP were included in models, SBP was positively, and DBP negatively 
related to stroke risk in Europeans, whereas in South Asians, DBP remained positively 
associated with stroke risk (ethnicity interaction p<0·001), in addition to SBP. In the MAP + 
PP models, PP but not MAP was associated with stroke in Europeans, whereas the opposite 
was true for South Asians; ethnicity interactions were present for both parameters.  
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There were no significant interactions for associations between each BP measure and 
diabetes, fasting glucose, HbA1c or HOMA2-IR (the latter three exposures as continuous 
variables) and stroke in age-adjusted models. However, inspection of graphical plots of 
incident stroke by dichotomised SBP or DBP plotted against dichotomised HbA1c indicated 
that participants in both the highest category for blood pressure measure and HbA1c appeared 
to have greater risk, compared with those in the lowest categories for each parameter, in 
South Asians but not Europeans (SBP: Europeans; (age-adjusted OR (95% CI) 0·80 (0·41, 
1·54), South Asians; 5·11(2·28,11·47), ethnic difference p=0·001, DBP: Europeans; 
0·77(0·39,1·54), South Asians; 5·96(2·25,15·77), ethnic difference p=0·001) (figure 2). 
Results were similar for fasting glucose. Relationships between SBP or DBP and age did not 
vary with ethnicity, nor were consistent ethnic differences observed for BP change between 
baseline and follow-up. Equally, there were no ethnic differences in associations between BP 
change measures and stroke. Of the original participants, 534 Europeans and 444 South 
Asians additionally attended the follow-up clinic in 2008-11.There were no ethnic differences 
in BP control in these individuals (supplementary table S1) or in the proportions of people 
with BP>140/90 mmHg taking anti-hypertensive medication at baseline or follow-up 
(baseline: 19% Europeans vs. 23% South Asians, p=0.39, follow-up: 66% vs. 86%, p=0.25). 
Sensitivity analyses showed that inclusion of participants on baseline anti-hypertensive 
medication (Europeans: 155/1530 (10%) and South Asians: 154/1228 (13%), p=0.04, table 
3), exclusion of participants with baseline diabetes (supplementary table S2), adjustment for 
diabetes development as a time-varying covariate (supplementary table S3) adjustment for 
HbA1c or HOMA2-IR instead of fasting glucose, use of an alternative formula for MAP,
21 
adjustment for anti-thrombotic medication use at follow-up (Europeans: 395/712 (55%), 
South Asians: 401/584 (69%), p<0.001) or AF at follow-up (Europeans: 96/712 (13%) and 
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South Asians 43/584 (7%), p<0.001) (table 4), substitution of BMI for WHR and additional 
adjustment for eGFR gave similar results to the main analyses. A sub-group analysis 
contrasting associations by younger vs. older age group (<55 years vs. ≥55 years) 
demonstrated little evidence for associations between BP measures and stroke risk in younger 
Europeans, whereas SBP and PP had strong positive associations with stroke in the older 
group. In contrast, for South Asians, associations between BP measures and stroke did not 
differ greatly by age group and were similar to those reported in the main analyses 
(supplementary table S4).   
Discussion  
South Asians had modestly higher SBP, DBP, and MAP than Europeans, though PP was 
similar. We report the following novel findings: 1) SBP, DBP, and MAP were more 
adversely associated with stroke in South Asians than Europeans, 2) when MAP + PP were 
considered together, PP but not MAP was detrimentally associated with stroke in Europeans, 
whilst the converse was true for South Asians, these findings persisted on adjustment for 
other cardiovascular risk factors, 3) associations between BP and stroke risk were greater in 
older (≥55 years) than younger Europeans, but similar by age group in South Asians, 4) the 
combined effects of high BP and high glycaemia appeared to be more deleterious in South 
Asians than Europeans.  
Our findings of higher blood pressure in South Asians than Europeans accord with most5, 6 
but not all22 previous studies. Also consistent with earlier work5, 6 we showed only marginally 
elevated SBP and DBP (mean difference +2mmHg and +3mmHg respectively) in South 
Asians when compared with Europeans; disparities that do not adequately explain the 1·5-
fold higher stroke incidence in the former group2, 4. 
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A novel finding was that SBP, DBP and MAP were more strongly associated with stroke in 
South Asians than Europeans. South Asians had more adverse glycaemic profiles than 
Europeans, thus we investigated whether the excess risk of stroke from high BP in South 
Asians was linked to greater hyperglycaemia. Neither excluding people with diabetes at 
baseline, nor adjusting for diabetes, hyperglycaemia, or insulin resistance in the main models 
altered the observed ethnic difference in the impact of BP measures on stroke. Nevertheless, 
the combination of high BP and glycaemia as dichotomized variables appeared more 
deleterious for South Asians than Europeans. We have previously shown that South Asians 
have poorer cerebral autoregulation than Europeans, in part due to greater levels of 
hyperglycaemia. 23 This may enhance the South Asian vulnerability to stroke. 
Since DBP tends to plateau or fall in Europeans after approximately 55 years of age,24 we 
postulated that the greater effects of DBP on stroke risk in South Asians were due to 
differences in this age-related DBP decline; this was not the case, nor were there ethnic 
differences in the impact of BP change over 20 year follow-up on stroke risk. Additionally 
we explored the influence of medication use over follow-up. Our main analyses excluded 
people in receipt of anti-hypertensive medication at baseline, but we also showed no ethnic 
differences in either BP control (BP≤140/90 mmHg) for participants receiving anti-
hypertensive medication at follow-up, or anti-hypertensive receipt for those with BP>140/90 
mmHg at baseline or follow-up. This suggests ethnic differences in BP management and 
control in those with hypertension are unlikely to contribute to the excess risk of stroke in 
South Asians with higher BP, commensurate with findings from UK primary care data.25 In 
addition, adjustment for anti-thrombotic use at follow-up, which was greater in South Asians 
than Europeans,  did not alter the ethnic differential in associations between SBP, DBP, or 
MAP and stroke. Though we did not have data on use of anti-thrombotic medication at 
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baseline, use of these drugs in primary prevention was not widespread until the late 1990’s, 
hence any confounding effects are likely to be less than for contemporary cohorts. Our 
follow-up data indicated a greater prevalence of atrial fibrillation/ flutter (AF) in Europeans 
than South Asians (baseline data were unavailable), in keeping with previous findings,26 
however, a sensitivity analysis restricted to follow-up data indicated that AF did not have an 
important impact on associations between BP and stroke in either ethnic group. Other 
possible explanations for the ethnic differences in these associations include inter-ethnic 
variation in diurnal BP. However a previous study reported no ethnic differences in 24 hour 
BP, including nocturnal dipping, 27 and unpublished data from the SABRE cohort is 
consistent with this. Alternatively, genetic or epigenetic factors may contribute; we were 
unable to explore these further. 
We contrasted the relative contribution of the hemodynamic components of BP: PP and 
MAP, to stroke risk by examining models featuring these measures in combination. These 
indicated that PP was more adversely related to stroke than MAP in Europeans, consistent 
with the postulated role of arterial stiffness in cardiovascular risk for this ethnic group, 
demonstrated in the Framingham Heart Study.7  Conversely, MAP was much more adversely 
related to stroke risk than PP in South Asians. This may imply that increased peripheral 
resistance might be relatively more important to stroke risk in this group.28 Reasons for these 
ethnic differences are unknown, but they are consistent with evidence indicating a 
comparatively greater prevalence of intracranial and small vessel disease in South Asian 
people with stroke5, 26 and increased microvascular disease in South Asian individuals.29 
These mechanisms could be further studied by observing ethnic differences in microvascular 
responses to PP and MAP, e.g. using near infra-red spectroscopy (NIRS).30 If stroke 
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pathogenesis differs by ethnicity, this has important implications for risk management 
strategies, particularly for measures of BP. 
This longitudinal study is unique in comparing associations between BP and stroke in 
Europeans and South Asians, with adequate power to show ethnic differences and excellent 
follow-up rates. A single BP measurement may not adequately represent lifetime exposure, 
however we found no evidence of marked differences in age-related changes in BP by 
ethnicity and imprecision in measurement of exposures is more likely to obscure differences. 
Since the main analyses did not involve comparison of baseline and follow-up BPs, baseline/ 
follow-up differences in BP ascertainment method are unlikely to have affected results. 
Potential confounders may have varied over time, especially use of anti-hypertensive, lipid-
lowering and anti-thrombotic medication. We did not have sufficient power to compare 
stroke sub-types or fatal and non-fatal events, though the majority of strokes in both ethnic 
groups are ischaemic in nature31 and data from the Prospective Studies Collaboration 
suggests the BP-associated risks for ischaemic and haemorrhagic strokes are similar.2 Our 
study was limited to men and the South Asian population was of Indian origin, mostly 
Punjabi Sikhs, resident in the UK, thus caution should be exercised in applying these findings 
to women and other South Asian sub-groups. 
Perspectives 
To summarise, in this longitudinal comparison of UK ethnic groups, we have shown that 
SBP, and particularly DBP and MAP, were more strongly associated with stroke risk in South 
Asians than Europeans, independent of other cardiovascular risk factors. Associations 
remained strong across the age spectrum in South Asians, unlike Europeans where 
associations were apparent only in those aged≥55 years. If substantiated, our findings support 
the need for trials of BP reduction beyond current thresholds, and in younger individuals, to 
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address the greater stroke risk in South Asian groups. The majority of cardiovascular risk 
scores guiding primary prevention utilise SBP alone,9, 10 and it has been proposed that DBP 
may be largely immaterial to CVD risk and does not warrant measurement in clinical 
practice.8 Our findings suggest that DBP is an important therapeutic target for stroke 
prevention in South Asian men.  
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Novelty and significance 
What is new? 
- No studies compare associations between different blood pressure (BP) measures and 
stroke risk in South Asian and European groups.  
- Mid-life systolic (SBP), diastolic (DBP) and mean arterial BP (MAP) were more 
strongly related to stroke risk in South Asian than European men. Associations 
between pulse pressure (PP) and stroke were similar. 
- PP contributed most to stroke risk in Europeans, and MAP in South Asians. 
What is relevant? 
- Risk prediction scores are based on SBP, but DBP/ MAP may contribute more to 
stroke risk in South Asian groups. 
- More aggressive BP treatment thresholds may be warranted to address the excess 
stroke risk experienced by South Asians. 
- The different relative contributions of MAP and PP suggest ethnic differences in 
stroke pathogenesis. 
Summary 
Systolic, diastolic and mean arterial BP were more strongly associated with stroke risk in 
South Asian than European men.   
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Figure legends 
Figure 1. Follow-up of the SABRE cohort 1988-2011. 
Figure 2. Proportions of incident stroke by blood pressure and HbA1c categories in 
European and South Asian men: for A) SBP in Europeans, B) SBP in South Asians,  C) 
DBP in Europeans, and D) DBP in South Asians. Excludes participants with baseline 
stroke or receipt of anti-hypertensive medication. 
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Table 1. Baseline characteristics of European and South Asian men in the SABRE 
study, by stroke status. Excludes participants with baseline stroke or receipt of anti-
hypertensive medication. Data are n(%),  median (IQR) or mean±SD. *age-adjusted p for 
difference in participants who experienced stroke vs. those who did not,  †age-adjusted p for 
ethnic difference, regardless of stroke status. HbA1c available for 1082 Europeans and 803 
South Asians, eGFR available for 1015 Europeans and 959 South Asians. 
 Europeans South Asians  
Variable All 
No 
strok
e 
Stroke p* All 
No 
stroke 
Stroke p* p† 
n 1375 
1271 
(92) 
104(8) - 1074 
972 
(90) 
102 
(10) 
- - 
Age, years 
52 (46-
58) 
52 
(46-
58) 
51 (46-
56) 
<0.0
01 
50 
(45-
55) 
49 (44-
55) 
53 (48-
59) 
<0.00
1 
<0.0
01 
Ever 
smoked 
1011 
(74) 
928 
(73) 
83 (80) 0.21 
292 
(27) 
260 
(27) 
32(32) 0.27 
<0.0
01 
Manual 
occupation 
852 
(62) 
778 
(61) 
74(71) 0.14 
819 
(77) 
736 
(76) 
83(82) 0.17 
<0.0
01 
Alcohol, 
units/ week 
12(3-
26) 
12(3-
26) 
13(1-
31) 
0.37 
3 (0-
15) 
3(0-
15) 
4(0-
20) 
0.34 0.003 
Veg/ fruit 
daily/ most 
days 
931 
(68) 
862 
(68) 
69(66) 0.58 
711 
(67) 
646 
(67) 
65(65) 0.36 0.99 
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Physical 
activity, 
MJ/wk 
11(7-
16) 
12(7-
16) 
11(7-
19) 
0.06 
10 (6-
13) 
10(6-
13) 
9(5-
14) 
0.08 
<0.0
01 
Waist/hip 
ratio 
0.94±0
.07 
0.94±
0.06 
0.95±0.
08 
0.41 
0.98± 
0.06 
0.98± 
0.06 
1.00± 
0.06 
0.08 
<0.0
01 
BMI, kg/m2 
26.1± 
3.8 
26.1± 
3.7 
25.9± 
4.1 
0.51 
25.7±  
3.2 
25.7± 
3.1 
25.8± 
3.7 
0.71 0.02 
HDL, 
mmol/l 
1.3 
(1.1-
1.5) 
1.3 
(1.1-
1.5) 
1.3 
(1.1-
1.5) 
0.73 
1.2 
(1.0-
1.4) 
1.2 
(1.0-
1.4) 
1.2 
(1.0-
1.4) 
0.98 
<0.0
01 
Triglycerid
es, mmol/l 
1.4 
(1.0-
2.1) 
1.4 
(1.0-
2.1) 
1.6 
(1.1-
2.2) 
0.20 
1.7 
(1.2-
2.5) 
1.7 
(1.2-
2.5) 
1.8 
(1.1-
2.6) 
0.57 
<0.0
01 
Total/ HDL 
cholesterol 
4.7 
(3.8-
5.9) 
4.7 
(3.8-
5.9) 
4.8 
(3.9-
5.6) 
0.93 
5.0 
(4.2-
6.1) 
5.0 
(4.2-
6.1) 
5.1 
(4.4-
6.1) 
0.23 
<0.0
01 
Diabetes 84 (6) 76(6) 8(8) 0.92 
212 
(20) 
168 
(17) 
44(43) 
<0.00
1 
<0.0
01 
Fasting 
glucose, 
mmol/l 
5.4 
(5.1-
5.9) 
5.4 
(5.1-
5.9) 
5.5 
(5.1-
5.9) 
0.26 
5.6 
(5.2-
6.2) 
5.6 
(5.1-
6.1) 
5.9 
(5.3-
7.7) 
<0.00
1 
<0.0
01 
Post-load 
glucose, 
mmol/l 
5.0 
(4.1-
5.9) 
5.0 
(4.1-
5.9) 
5.0 
(3.9-
5.8) 
0.14 
5.5 
(4.6-
6.6) 
5.5 
(4.6-
6.5) 
5.9 
(4.8-
8.3) 
0.01 
<0.0
01 
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HbA1c, % 
5.6 
(5.4-
5.8) 
5.6 
(5.4-
5.8) 
5.6 
(5.4-
5.8) 
0.24 
5.8 
(5.5-
6.2) 
5.8 
(5.5-
6.2) 
6.1 
(5.7-
6.9) 
0.02 
<0.0
01 
HOMA2-
IR 
0.8 
(0.6-
1.2) 
0.8 
(0.6-
1.2) 
0.7 
(0.5-
1.2) 
0.69 
1.2 
(0.8-
1.8) 
1.2 
(0.8-
1.8) 
1.4 
(0.9-
2.1) 
0.04 
<0.0
01 
eGFR, 
ml/min 
117± 
36 
118± 
36 
107± 40 0.05 
109± 
37 
109± 
37 
107± 
38 
0.81 
<0.0
01 
Median 
heart rate, 
bpm 
64 (57-
72) 
63 
(57-
72) 
65 (56-
71) 
0.71 
68 
(61-
75) 
67 (61-
75) 
71 (63-
77) 
0.03 
<0.0
01 
Systolic BP, 
mmHg 
122± 
16 
122± 
16 
127± 22 0.05 
124± 
17 
123± 
17 
134± 
17 
<0.00
1 
<0.0
01 
Diastolic 
BP, mmHg 
77±11 
77±1
1 
76±12 0.40 80±10 80±10 84±11 
<0.00
1 
<0.0
01 
Mean 
arterial BP, 
mmHg 
92±12 
92±1
1 
93±14 0.70 95±12 94±11 
101±1
2 
<0.00
1 
<0.0
01 
Pulse 
pressure, 
mmHg 
45±12 
45±1
1 
50±17 
0.00
1 
44±13 43±12 50±13 0.003 0.90 
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Table 2. Associations between baseline blood pressure measures and incident stroke, by 
ethnicity. Excludes participants with baseline stroke or receipt of anti-hypertensive 
medication. Data are odds ratios (OR) for a 1SD increase in BP measure unless otherwise 
stated, *p<0·05, †p<0·01, ‡p<0·001, §p for ethnicity x BP interaction. ||Cardiovavscular 
disease (CVD) risk factors comprise: smoking, WHR, total/ HDL- cholesterol ratio, diabetes, 
fasting glucose, physical activity and heart rate. SBP=systolic blood pressure, DBP=diastolic 
blood pressure, MAP= mean arterial blood pressure, PP=pulse pressure.  
BP 
measure 
Model factors 
Europeans South Asians 
OR 95% CI OR 95% CI p§ 
SBP 
Age 1·21 1·00,1·47* 1·63 1·34,1·97‡ 0·04 
Age + CVD risk 
factors|| 
 
1·22 0·98,1·51 1·56 1·24,1·95‡ 0·04 
DBP 
Age 0·91 0·74, 1·13 1·64 1·33,2·03‡ <0·001 
Age + CVD risk 
factors|| 
 
0·90 0·71,1·13 1·68 1·32,2·15‡ <0·001 
MAP 
Age 1·04 0·85, 1·28 1·69 1·38,2·08‡ 0·001 
Age + CVD risk 
factors|| 
 
1·04 0·82,1·30 1·69 1·34,2·14‡ 0·001 
PP 
Age 1·39 1·15, 1·68† 1·35 1·10, 1·64† 0·73 
Age + CVD risk 
factors|| 
 
1·40 1·13,1·72† 1·24 0·99,1·55 0·80 
SBP 
Age 
1·58 1·22,2·07† 1·38 1·04,1·82* 0·44 
DBP 0·66 0·50,0·87† 1·28 0·95,1·74 0·001 
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SBP 
DBP 
Age + CVD risk 
factors|| 
 
1·59 1·20,2·13† 1·24 0·91,1·70 0·50 
0·66 0·49,0·89† 1.43 1·01,2·01† 0·001 
MAP 
PP 
Age 
0·88 0·71,1·11 1·64 1·30,2·08‡ <0·001 
1·46 1·18,1·81‡ 1·06 0·84,1·34 0·04 
MAP 
PP 
Age + CVD risk 
factors|| 
0·88 0·68,1·12 1·72 1·31,2·25‡ <0·001 
1·47 1·17,1·85† 0·97 0·75,1·26 0·04 
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Table 3. Associations between blood pressure measures and incident stroke in men, 
including participants in receipt of baseline anti-hypertensive medication.  A correction 
of +10/5 mmHg was added to the blood pressures of participants in receipt of anti-
hypertensive medication. Data are odds ratios (OR) for a 1SD increase in BP measure unless 
otherwise stated, *p<0·05, †p<0·01, ‡p<0·001, §p for ethnicity x BP interaction. 
||Cardiovascular disease (CVD) risk factors comprise: smoking, WHR, total/ HDL- 
cholesterol ratio, diabetes, fasting glucose, physical activity and heart rate. SBP=systolic 
blood pressure, DBP=diastolic blood pressure, MAP= mean arterial blood pressure PP=pulse 
pressure. 
BP 
meas
ure 
Model factors 
Europeans South Asians 
OR 95% CI OR 95% CI p§ 
SBP 
Age 1·32 1·11,1·57† 1·61 1·35,1·92‡ 0·16 
Age + CVD risk 
factors|| 
 
1·31 1·08,1·58† 1·52 1·25,1·86‡ 0·16 
DBP 
Age 1·01 0·85,1·21 1·55 1·28,1·80‡ 0·001 
Age + CVD risk 
factors|| 
 
1·02 0·83,1·24 1·53 1·23,1·89‡ 0·002 
MAP 
Age 1·15 0·97,1·38 1·64 1·36,1·97‡ 0·009 
Age + CVD risk 
factors|| 
 
1·16 0·95,1·41 1·58 1·29,1·95‡ 0·01 
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PP 
Age 1·44 1·21,1·70‡ 1·39 1·17,1·66‡ 0·61 
Age + CVD risk 
factors|| 
1·40 1·16,1·67‡ 1·29 1·06,1·57* 0·69 
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Table 4. Associations between blood pressure and incident stroke, adjusting for 
presence of anti-thrombotic medication (anti-coagulant or anti-platelet agents) or atrial 
fibrillation at follow-up, by ethnicity. Participants are men not in receipt of baseline anti-
hypertensive medication with follow-up data for medication use and presence of atrial 
fibrillation; n=712 European and 584 South Asian men. Data are odds ratios (OR) for a 1SD 
increase in BP measure, *p<0·05, †p<0·01, ‡p<0·001, §p for ethnicity x BP interaction. 
SBP=systolic blood pressure, DBP=diastolic blood pressure, MAP= mean arterial blood 
pressure PP=pulse pressure. 
BP 
measur
e 
Model factors 
Europeans South Asians 
OR 95% CI OR 95% CI p§ 
SBP 
Age 1·02 0·76,1·36 1·68 1·28,2·20‡ 0·02 
Age + anti-thrombotic 
medication at follow-up 
0·90 0·66,1·22 1·57 1·18,2·08† 0·006 
Age + atrial fibrillation 
at follow-up 
 
1.00 0.75,1.34 1.64 1.24,2.17 0.02 
DBP 
Age 0·82 0·62, 1·09 1·66 1·24,2·21† 0·001 
Age + anti-thrombotic 
medication at follow-up 
0·78 0·58, 1·04 1·54 1·14,2·08† 0·001 
Age + atrial fibrillation 
at follow-up 
 
0.83 0.63,1.10 1.58 1.18,2.13 0.002 
MAP Age 0·89 0·66, 1·19 1·70 1·29, 2·24‡ 0·001 
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Age + anti-thrombotic 
medication at follow-up 
0·81 0·60,1·09 1·59 1·20,2·11† 0·001 
Age + atrial fibrillation 
at follow-up 
 
0.88 0.66,1.19 1.64 1.24,2.18 0.002 
PP 
Age 1·20 0·92, 1·57 1·45 1·07, 1·95* 0·36 
Age + anti-thrombotic 
medication at follow-up 
1·10 0·83,1·44 1·37 1·02,1·85* 0·21 
Age + atrial fibrillation 
at follow-up 
1.17 0.90,1.54 1.45 1.08,1.97 0.27 
 
 
